Effect of conversion from azathioprine to mycophenolate mofetil on renal function in stable kidney transplant recipients
Mehmet Emin Usta, Alparslan Ersoy, Yavuz Ayar
Abstract
Open-access reader
Mehmet Emin Usta, Alparslan Ersoy, Yavuz Ayar
Abstract
Open-access reader
Abstract Aim: This study investigated the effect of mycophenolate mofetil (MPA) treatment instead of azathioprine (AZA) on renal function after kidney transplantation. Methods: Thirteen of all recipients were taking a cyclosporine-based regimen and serum creatinine levels were above 1.5 mg/dL. In 13 patients, MPA treatment was started instead of AZA. Renal functions were evaluated for 12 months after MPA treatment. Results: Serum creatinine levels increased from 2.11±0.48 mg/dL to 2.16±0.72 mg/dL at 12th months. This increase was not statistically significant. Serum creatinine levels decreased in 5 of 13 patients. Conclusion: In selected patients, conversion from AZA to MPA may slow down the rate of deterioration in graft functions.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract Aim: This study investigated the effect of mycophenolate mofetil (MPA) treatment instead of azathioprine (AZA) on renal function after kidney transplantation. Methods: Thirteen of all recipients were taking a cyclosporine-based regimen and serum creatinine levels were above 1.5 mg/dL. In 13 patients, MPA treatment was started instead of AZA. Renal functions were evaluated for 12 months after MPA treatment. Results: Serum creatinine levels increased from 2.11±0.48 mg/dL to 2.16±0.72 mg/dL at 12th months. This increase was not statistically significant. Serum creatinine levels decreased in 5 of 13 patients. Conclusion: In selected patients, conversion from AZA to MPA may slow down the rate of deterioration in graft functions.
Key concepts: Mycophenolate, Azathioprine, Creatinine, Medicine, Renal function, Urology, Regimen, Kidney